Royalty Pharma (RPRX) Equity Income (2019 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Equity Income (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 4.08 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.57 Bn | 21.04 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08 Mn |
| Mar 31, 2026 | 21.76 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 15.95 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 31.65 Mn |
| Sep 30, 2024 | 10.41 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | -14.15 Mn |
| Dec 31, 2023 | 268,000.00 |
| Sep 30, 2023 | -5.22 Mn |
| Jun 30, 2023 | -770,000.00 |
| Mar 31, 2023 | 34.61 Mn |
| Dec 31, 2022 | -6.86 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | 737,000.00 |
| Mar 31, 2022 | 397,000.00 |
| Dec 31, 2021 | -38.02 Mn |
| Sep 30, 2021 | 2.75 Mn |